Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hyundai Motor (005380) – (Correction) Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2024-06-25

Posted on June 25, 2024August 12, 2026 By K-STOCK Editor No Comments on [Disclosure] Hyundai Motor (005380) – (Correction) Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2024-06-25

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hyundai Motor disclosed a correction regarding its participation in the rights issue of its subsidiary, 42dot Inc., updating the total shares to be acquired to 5,095,446 shares for KRW 657.31B.

📊 [Key Disclosure Contents & Major Figures Summary]

  1. Correction Overview
  • Corrected Document: Decision on Acquisition of Shares and Equity Securities of Other Corporation (Voluntary Disclosure) (Originally filed on June 4, 2024)
  • Date of Correction: 2024-06-25
  • Reason for Correction: Revisions following the acquisition of forfeited shares in the rights issue
  1. Key Corrected Details (Acquisition & Shareholding)
  • Shares to be Acquired: (Before) 5,042,099 shares ➔ (After) 5,095,446 shares (+53,347 shares)
  • Acquisition Amount: (Before) KRW 650,431,000,000 ➔ (After) KRW 657,313,000,000 (+KRW 6,882,000,000)
  • Total Shares Owned After Acquisition: (Before) 7,571,258 shares ➔ (After) 7,624,605 shares
  • Equity Ratio After Acquisition: (Before) 56.93% ➔ (After) 57.33% (+0.40%p)
  1. Target Company & Transaction Structure
  • Target Company: 42dot Inc. (Subsidiary of Hyundai Motor, SDV Software Developer)
  • Acquisition Method: Cash acquisition via participation in shareholder-allocated rights offering
  • Issue Price per Share: KRW 129,000
  • Phased Payment Schedule:
    • Tranche 1 (Completed): Payment Date 2023-05-30 / 1,610,413 shares / KRW 207,743M
    • Tranche 2 (Corrected): Scheduled Date 2024-06-27 / 1,217,157 shares / KRW 157,013M (Previously: June 2024, 1,179,564 shares, KRW 152,164M)
    • Tranche 3 (Corrected): Scheduled Date During 2025 / 2,267,876 shares / KRW 292,556M (Previously: 2,252,122 shares, KRW 290,524M)
  1. Other Important Notes
  • Acquisition amount represents 0.72% of total equity (KRW 90,896,545,000,000 based on 2022 consolidated financial statements).
  • Tranche 3 figures remain subject to potential changes during the rights offering process.
  • Replaces previous clarification disclosures regarding media reports dated December 5, 2022.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Phased Capital Injection Execution and Final Shareholding Ratio

This corrected disclosure reflects adjustments in the number of shares and investment amounts for Tranches 2 and 3 due to the re-allocation of forfeited shares in 42dot Inc. Checking whether the capital contributions are completed as scheduled on June 27, 2024 for Tranche 2 and during 2025 for Tranche 3 is important for determining whether the transaction has been fully executed. Further details can be verified in future official disclosures, such as subsequent corrective filings or Quarterly, Half-Year, and Annual Reports.

📢 Disclaimer & Source Information

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Automotive

Post navigation

Previous Post: [Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-25
Next Post: [Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract / 2024-06-25

Related Posts

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-25 Disclosures
[Disclosure] KEPCO (015760 / KEP) – Decision to Convene General Meeting of Shareholders / 2026-04-10 Disclosures
[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Acquisition of Shares or Equity Securities of Other Corporations by Subsidiary / 2024-12-30 Disclosures
[Disclosure] SK Square (402340) – Report on Reason for Holding General Shareholders’ Meeting on Concentrated Date / 2025-02-25 Semiconductors
[Disclosure] Hanwha Systems (272210) – (Correction) Resolution on Convening of General Meeting of Shareholders / 2026-03-06 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Decision on Stock Retirement / 2024-10-25 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] KEPCO (015760 / KEP) – Provisional Consolidated Earnings Results / 2026-08-12August 12, 2026
  • [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations (Correction) / 2026-08-10August 10, 2026
  • [Disclosure] KEPCO (015760 / KEP) – Financial Results Disclosure Schedule Announcement / 2026-08-07August 7, 2026
  • [Disclosure] KEPCO (015760 / KEP) – Investor Relations (IR) Holding Announcement / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme